Search





Search





News

All

Editors' Picks

Stocks

Indices

Market Movers

Commodities

Cryptocurrencies

Forex

Presentations

Earnings

Transcripts

Technical Analysis

Economic Indicator

Other

eHealth Q3 Revenue Falls 60% Amid Marketing Pullback

eHealth reported a 60% drop in Q3 2026 revenue as it reduced off-season marketing, while costs and cash flow improved and losses widened.

TradingKey

Thu, Nov 5

8x8 Raises FY2027 Outlook After Record Q2 Revenue

8x8 reported record fiscal Q2 2027 revenue, higher operating profit and positive cash flow, while raising several full-year guidance ranges despite gross-margin pressure.

TradingKey

Thu, Nov 5

Dave Raises 2026 Outlook as Q3 Revenue Climbs 31%

Dave raised its 2026 revenue and adjusted EBITDA guidance after Q3 revenue rose 31%, supported by member growth, ExtraCash volume and higher monetization.

TradingKey

Thu, Nov 5

Traeger Q3 Revenue Falls 40%, Full-Year Guidance Ranges Narrowed

Traeger’s Q3 fiscal 2026 revenue fell 40.4% to $74.7 million, adjusted EBITDA turned negative, and the company narrowed full-year guidance around unchanged midpoints.

TradingKey

Thu, Nov 5

Coherent Q1 Revenue Jumps 56%, FY2027 Growth Seen Above 60%

Coherent posted record Q1 fiscal 2027 revenue of $2.37 billion, driven by datacenter and communications demand, and expects full-year growth above 60%.

TradingKey

Thu, Nov 5

BillionToOne Raises 2026 Revenue Guidance as Q3 Sales Rise 47%

BillionToOne raised 2026 revenue guidance to $460 million-$470 million after Q3 revenue rose 47% to $123 million, with prenatal and oncology growth.

BillionToOne Inc

TradingKey

Thu, Nov 5

Bio-Rad Q3 Revenue Flat as Charges Push GAAP Margin Negative

Bio-Rad reported flat Q3 2026 revenue as Clinical Diagnostics growth offset weaker Life Science sales, while restructuring and impairment charges drove a GAAP operating loss.

Bio Rad Laboratories Inc

TradingKey

Thu, Nov 5

Arcutis Raises 2026 Sales Outlook as ZORYVE Revenue Rises 45%

Arcutis Biotherapeutics raised 2026 product sales guidance to $535 million-$545 million after Q3 ZORYVE revenue climbed 45% to $143.9 million.

Arcutis Biotherapeutics Inc

TradingKey

Thu, Nov 5

Accuray Q1 FY2027 Adjusted EBITDA Turns Positive as Product Sales Fall

Accuray’s Q1 FY2027 revenue fell 8% as product sales declined, but service growth and cost reductions helped adjusted EBITDA turn positive.

TradingKey

Thu, Nov 5

a.k.a. Brands Q3 Sales Rise 9.7% as Gross Margin Expands

a.k.a. Brands reported 9.7% Q3 2026 sales growth and wider margins, while outlining full-year guidance and continued retail and wholesale expansion.

AKA Brands Holding Corp

TradingKey

Thu, Nov 5

Qualcomm Q4 Revenue Falls as Automotive Hits Record, Data Center Ramp Takes Shape

Qualcomm’s Q4 fiscal 2026 non-GAAP revenue fell 7% as handset sales declined, while automotive revenue reached a record and the company outlined a major fiscal 2027 data-center ramp.

TradingKey

Thu, Nov 5

Palmer Square BDC Q3 Income Declines as Portfolio Shrinks

Palmer Square BDC reported lower Q3 2026 investment income and net investment income as net sales reduced its portfolio, while NAV rose and leverage declined.

Palmer Square Capital BDC Inc

TradingKey

Thu, Nov 5

Pattern Group Q3 Revenue Rises 38% as Net Income Turns Positive

Pattern Group’s Q3 2026 revenue rose 38% to $886 million as it returned to profit, strengthened retention and issued full-year guidance.

Pattern Group Inc

TradingKey

Thu, Nov 5

Power Integrations Q3 Revenue Rises 6% on GaN, Industrial Growth

Power Integrations reported 6% year-over-year Q3 2026 revenue growth, stronger non-GAAP profitability, GaN and industrial gains, and issued its Q4 outlook.

Power Integrations Inc

TradingKey

Thu, Nov 5

PACS Q3 2026 Revenue Rises 11.5% as Acquisitions Expand Footprint

PACS Group’s Q3 2026 revenue rose 11.5% and adjusted EBITDA climbed 33.6% as the post-acute care provider expanded through acquisitions and outlined its full-year outlook.

TradingKey

Thu, Nov 5

Myriad Genetics Raises 2026 Revenue Midpoint, Advances $210 Million Prenatal Sale

Myriad Genetics raised the midpoint of its 2026 revenue outlook as Q3 profitability improved sequentially and it advanced the $210 million Prenatal Health sale.

Myriad Genetics Inc

TradingKey

Thu, Nov 5

Niagen Bioscience Q3 Sales Fall 20% as Company Posts Net Loss

Niagen Bioscience reported a 20% decline in Q3 2026 sales and a $1.2 million net loss, while adjusted EBITDA and operating cash flow stayed positive.

Niagen Bioscience Inc

TradingKey

Thu, Nov 5

Magnite Raises 2026 Outlook as Q3 CTV Contribution Jumps 39%

Magnite’s Q3 2026 Contribution ex-TAC rose 20% as CTV grew 39%, prompting higher full-year growth, margin and free-cash-flow forecasts.

TradingKey

Thu, Nov 5

McKesson Raises FY2027 Outlook as Q2 Adjusted EPS Rises 18%

McKesson raised its fiscal 2027 adjusted EPS outlook after Q2 revenue rose 8% and adjusted EPS increased 18%, led by specialty distribution and oncology.

TradingKey

Thu, Nov 5

LegalZoom Q3 Revenue Rises 3% as Subscriptions Offset Transaction Decline

LegalZoom’s Q3 2026 revenue rose 3% as subscription growth offset weaker transaction revenue, while adjusted EBITDA increased 8% and margins expanded.

LegalZoom.com Inc

TradingKey

Thu, Nov 5

1...12 13 14

14/55

Featured Tools

marketing_marketsTitle

calendar_economicCalendar

Economic Calendar

search.intelligent.strategy

article_asider_weekly_report

Popular Instruments

link

Name

Price

Chg%

link

Today’s Market Recap: Nasdaq Falls Over 5%, AI Stocks Plunge as Nvidia Drops Over 9%, Micron Falls Over 17%, SanDisk Drops Over 22%

Nasdaq Rebounds 1% After Yesterday's 5% Slump Led by Tech, SpaceX Shares Jump Over 8%

Microsoft to drop rented computing capacity from Oracle

Wizstar Launches Wizshot 1.0, Its First In-House Video Generation Model, Making High-Quality AI Video Creation More Cost-Efficient

Berkshire Hathaway Q3 Earnings Preview: Insurance Profits and Cash Deployment in Focus as UBS Raises Class B Price Target to $628

link

Cloudflare Inc Stock (NET) Closed Up by 9.91% on Nov 6: What Investors Need To Know

23 hours ago

Abbott Laboratories Stock (ABT) Closed Down by 3.23% on Nov 6: What Investors Need To Know

23 hours ago

ASE Technology Holding Co Ltd Stock (ASX) Closed Up by 6.43% on Nov 6: Facts Behind the Movement

23 hours ago

Quanta Services Inc Stock (PWR) Closed Up by 6.25% on Nov 6: What Investors Need To Know

23 hours ago

Netflix Inc Stock (NFLX) Closed Down by 3.28% on Nov 6: A Full Analysis

23 hours ago